- active not recruitingPHASE3
Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease
This study looks at the long-term safety and effects of a medicine called valbenazine for people with Huntington's disease who experience involuntary movements called chorea. It's for those who have been in a previous study or meet specific new criteria.
United States · Canada - enrolling by invitationPHASE3
Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canada
This study looks at the long-term safety of a medicine called valbenazine for people in Canada with Huntington's disease who experience involuntary movements. It's for those who have already been in a previous study with this medicine.
Canada